Divalproex Sodium
- Product NDC
- 0615-8330
- 11-digit product format
- 006158330
- Labeler code
- 0615
- Product ID
- 0615-8330_30767d3b-2c30-43f2-bcc5-b9483c964e42
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Divalproex Sodium
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, Inc dba Vangard Labs
- Application
- ANDA090070
- Marketing category
- ANDA
- Marketing start
- 2013-08-11
- Marketing end
- 2022-08-31
- Substance
- DIVALPROEX SODIUM
- Active strength
- 500 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0615-8330-30 | 00615833030 | 6 BLISTER PACK in 1 BOX, UNIT-DOSE (0615-8330-30) > 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK | 6 blister pack | 2020-01-02 | 2022-07-31 | No | No | Current |
| 0615-8330-39 | 00615833039 | 30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8330-39) | | 2020-01-06 | 2022-08-31 | No | No | Current |